Zoglo’s Incredible Food Corp. (ZOG.C) announced today that it will be listing 12 plant-based food products from its new Incredible™ product line at 130 Metro Inc. supermarket locations across…
Robertson
Axsome Therapeutics (AXSM.Q) announced today that its AXS-05 has met primary and key secondary endpoints in the MERIT (Mechanistic Evaluation of Response in TDR) Phase 2 trial. Additionally, the…
Spectrum Pharmaceuticals (SPPI.Q) announced today that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Company’s Biologics License Application (BLA)…
Sphere 3D (ANY.NASDAQ) announced today that it has entered into an agreement with Herford Advisors, a privately-held company that provides turnkey mining solutions, to provide a six month exclusive…
FansUnite (FANS.C) announced today that its subsidiaries, Askott Entertainment Inc. and E.G.G. Limited, have been granted licenses from the UK Gambling Commission. “The approval of both the B2B and…
Zoglo’s Incredible Food Corp. (ZOG.C) announced today that it has launched a dozen new plant-based products, following its listing on the Canadian Securities Exchange on July 26, 2021. “Zoglo’s…
PharmaTher (PHRM.C) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for ketamine in the treatment of Amyotrophic Lateral Sclerosis (ALS), also…
Alterity Therapeutics (ATHE.Q) announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the Company’s patent application No.17/239,375. “As the scientific…
BioVaxys Technology (BIOV.C) announced today that Immunologist Yvelise Barrios, MD, PhD, has joined the Company as a Scientific Adviser to support development of CoviDTH. Furthermore, studies conducted by Dr….
Medexus Pharmaceuticals (MDP.T) announced today that medac GmbH, the Company’s licensor for treosulfan, has received a Complete Response Letter (CRL) from the Food and Drug Administration (FDA) in response…